A detailed history of Ddfg, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Ddfg, Inc holds 264 shares of LLY stock, worth $206,756. This represents 0.07% of its overall portfolio holdings.

Number of Shares
264
Previous 264 -0.0%
Holding current value
$206,756
Previous $239 Million 2.15%
% of portfolio
0.07%
Previous 0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $156,340 - $209,161
264 New
264 $205 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ddfg, Inc Portfolio

Follow Ddfg, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ddfg, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ddfg, Inc with notifications on news.